Immune Therapeutics Inc. (IMUN) 0.1000 $IMUN
ClearTrust, LLC is Immune Therapeutics' New Transfer Agent and Support Provider
PR Newswire - Mon Jan 26, 2:44PM CST
Dear Immune Therapeutics, Inc. (OTC-BB: IMUN) Shareholder:
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
PR Newswire - Fri Jan 23, 2:15PM CST
Immune Therapeutics, Inc. (OTC-BB: IMUN) today announced the signing of the agreement with KRS Global Biotechnology, Inc. for the compounding, packaging and distributing of its naltrexone tablets. The tablets will be compounded for shipment in the United States.
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
PR Newswire - Wed Jan 21, 9:00AM CST
Immune Therapeutics, Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, today announced that Vincent Butta, a new director appointed to fill a vacancy, and Edward Teraskiewicz, a director elected at the 2014 Annual Meeting of Shareholders, joined the Board on January 13, 2015.
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer
PR Newswire - Wed Jan 14, 11:53AM CST
Immune Therapeutics Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, today announced the appointment of Seth Elliott as President and Chief Operating Officer.
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations
PR Newswire - Thu Jan 08, 9:00AM CST
Immune Therapeutics Inc. (OTC:BB IMUN) - The Jack Brewer Foundation (JBF Worldwide) and Immune Therapeutics, Inc. announced today a first-of-its-kind donation program to improve access to treatment to prevent cervical cancer that until now has been unavailable to the women of Malawi, Africa.
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress
PR Newswire - Mon Jan 05, 9:00AM CST
Immune Therapeutics Inc. (OTCBB: IMUN), a biopharmaceutical company focused on the development and commercialization of targeted immune therapies, announced today that its Chief Executive Officer Noreen Griffin issued a letter to shareholders highlighting the significant progress the company has made toward its vision of becoming a leading developer of immune therapies.
ClearTrust, LLC is Immune Therapeutics' New Transfer Agent and Support Provider
PR Newswire - Mon Jan 26, 2:44PM CST
Dear Immune Therapeutics, Inc. (OTC-BB: IMUN) Shareholder:
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
PR Newswire - Fri Jan 23, 2:15PM CST
Immune Therapeutics, Inc. (OTC-BB: IMUN) today announced the signing of the agreement with KRS Global Biotechnology, Inc. for the compounding, packaging and distributing of its naltrexone tablets. The tablets will be compounded for shipment in the United States.
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
PR Newswire - Wed Jan 21, 9:00AM CST
Immune Therapeutics, Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, today announced that Vincent Butta, a new director appointed to fill a vacancy, and Edward Teraskiewicz, a director elected at the 2014 Annual Meeting of Shareholders, joined the Board on January 13, 2015.
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer
PR Newswire - Wed Jan 14, 11:53AM CST
Immune Therapeutics Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, today announced the appointment of Seth Elliott as President and Chief Operating Officer.
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations
PR Newswire - Thu Jan 08, 9:00AM CST
Immune Therapeutics Inc. (OTC:BB IMUN) - The Jack Brewer Foundation (JBF Worldwide) and Immune Therapeutics, Inc. announced today a first-of-its-kind donation program to improve access to treatment to prevent cervical cancer that until now has been unavailable to the women of Malawi, Africa.
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress
PR Newswire - Mon Jan 05, 9:00AM CST
Immune Therapeutics Inc. (OTCBB: IMUN), a biopharmaceutical company focused on the development and commercialization of targeted immune therapies, announced today that its Chief Executive Officer Noreen Griffin issued a letter to shareholders highlighting the significant progress the company has made toward its vision of becoming a leading developer of immune therapies.
